Drug Susceptibility in Leishmania Isolates Following Miltefosine Treatment in Cases of Visceral Leishmaniasis and Post Kala-Azar Dermal Leishmaniasis

BACKGROUND: With widespread resistance to antimonials in Visceral Leishmaniasis (VL) in the Indian subcontinent, Miltefosine (MIL) has been introduced as the first line therapy. Surveillance of MIL susceptibility in natural populations of Leishmania donovani is vital to preserve it and support the V...

Descripción completa

Detalles Bibliográficos
Autores principales: Bhandari, Vasundhra, Kulshrestha, Arpita, Deep, Deepak Kumar, Stark, Olivia, Prajapati, Vijay Kumar, Ramesh, V., Sundar, Shyam, Schonian, Gabriele, Dujardin, Jean Claude, Salotra, Poonam
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Public Library of Science 2012
Materias:
Research Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3358331/
https://www.ncbi.nlm.nih.gov/pubmed/22629478
http://dx.doi.org/10.1371/journal.pntd.0001657

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3358331/
https://www.ncbi.nlm.nih.gov/pubmed/22629478
http://dx.doi.org/10.1371/journal.pntd.0001657

Ejemplares similares